Erratum: A distinct subgroup of cardiomyopathy patients characterized by transcriptionally active cardiotropic erythrovirus and altered cardiac gene expression (Basic Res Cardiol (2013) 108 (372) DOI 10.1007/s00395-013-0372-y);A distinct subgroup of cardiomyopathy patients characterized by transcriptionally active cardiotropic erythrovirus and altered cardiac gene expression

Basic Research in Cardiology

Volumn 108, Issue 5, 2013, Pages

  Kuhl, U ^a   Lassner, D ^b   Dorner, A ^a   Rohde, M ^b   Escher, F ^a   Seeberg, B ^a   Hertel, E ^a   Tschope, C ^a   Skurk, C ^a   Gross, U M ^b   Schultheiss, H P ^a   Poller, W ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Institut Kardiale Diagnostik und Therapie (IKDT)   (Germany)

Author keywords

Cardiomyopathy; Erythrovirus; Virus latency; Virus reactivation

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ADIPONECTIN RECEPTOR 2; BETA INTERFERON; INTERLEUKIN 10; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; VIRUS PROTEIN;

ADULT; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; ERYTHEMA INFECTIOSUM; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HEART MUSCLE BIOPSY; HUMAN; HUMAN PARVOVIRUS B19; HUMAN TISSUE; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL RESPIRATION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; TRANSCRIPTION INITIATION; VIRUS LATENCY; VIRUS REACTIVATION;

EID: 84881094363     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-013-0394-5     Document Type: Erratum

References (40)

1. Angelow A, Weitmann K, Schmidt M, Schwedler S, Vogt H, Havemann C, Staudt A, Felix SB, Stangl K, Klingel K, Kandolf R, Kuhl U, Lassner D, von Schlippenbach J, Schultheiss HP, Hoffmann W (2009) The German transregional collaborative research centre 'Inflammatory Cardiomyopathy - Molecular Pathogenesis and Therapy'. Methods and baseline results from a 3-centre clinical study. Cardiology 113:222-230. doi: 10.1159/000203404
2. Bock CT, Klingel K, Kandolf R (2010) Human parvovirus B19-associated myocarditis. N Engl J Med 362:1248-1249. doi: 10.1056/NEJMc0911362
3. Bonsch C, Zuercher C, Lieby P, Kempf C, Ros C (2010) The globoside receptor triggers structural changes in the B19Virus capsid that facilitate virus internalization. J Virol 84:11737-11746. doi: 10.1128/JVI.01143-10
4. Bowles NE, Richardson PJ, Olsen EG, Archard LC (1986) Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1:1120-1123. doi: 10.1016/S0140-6736(86)91837-4
5. Breinholt JP, Moulik M, Dreyer WJ, Denfield SW, Kim JJ, Jefferies JL, Rossano JW, Gates CM, Clunie SK, Bowles KR, Kearney DL, Bowles NE, Towbin JA (2010) Viral epidemiologic shift in inflammatory heart disease: the increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients. J Heart Lung Transpl 29:739-746. doi: 10.1016/j.healun.2010.03.003
6. Brown KE, Anderson SM, Young NS (1993) Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114-117. doi: 10.1126/science.8211117 (Pubitemid 23338882)
7. Brown KE, Hibbs JR, Gallinella G, Anderson SM, Lehman ED, McCarthy P, Young NS (1994) Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 330:1192-1196. doi: 10.1056/NEJM199404283301704 (Pubitemid 24121988)
8. De Regge N, Van Opdenbosch N, Nauwynck HJ, Efstathiou S, Favoreel HW (2010) Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons in vitro. PLoS One 5(9). doi: 10.1371/journal.pone.0013076
9. Donoso Mantke O, Nitsche A, Meyer R, Klingel K, Niedrig M (2004) Analysing myocardial tissue from explanted hearts of heart transplant recipients and multi-organ donors for the presence of parvovirus B19 DNA. J Clin Virol 31:32-39. doi: 10.1016/j.jcv.2003.12.013 (Pubitemid 39024382)
10. Duechting A, Tschope C, Kaiser H, Lamkemeyer T, Tanaka N, Aberle S, Lang F, Torresi J, Kandolf R, Bock CT (2008) Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells. J Virol 82:7942-7952. doi: 10.1128/JVI.00891-08
11. Gruhle S, Sauter M, Szalay G, Ettischer N, Kandolf R, Klingel K (2012) The prostacyclin agonist iloprost aggravates fibrosis and enhances viral replication in enteroviral myocarditis by modulation of ERK signaling and increase of iNOS expression. Basic Res Cardiol 107:287. doi: 10.1007/s00395-012-0287-z
12. Guan W, Cheng F, Yoto Y, Kleiboeker S, Wong S, Zhi N, Pintel DJ, Qiu J (2008) Block to the production of full-length B19Virus transcripts by internal polyadenylation is overcome by replication of the viral genome. J Virol 82:9951-9963. doi: 10.1128/JVI.01162-08
13. Guan W, Wong S, Zhi N, Qiu J (2009) The genome of human parvovirus B19 can replicate in nonpermissive cells with the help of adenovirus genes and produces infectious virus. J Virol 83:9541-9553. doi: 10.1128/JVI.00702-09
14. Kuethe F, Lindner J, Matschke K, Wenzel JJ, Norja P, Ploetze K, Schaal S, Kamvissi V, Bornstein SR, Schwanebeck U, Modrow S (2009) Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Clin Infect Dis 49:1660-1666. doi: 10.1086/648074
15. Kuhl U, Lassner D, Pauschinger M, Gross UM, Seeberg B, Noutsias M, Poller W, Schultheiss HP (2008) Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy. J Med Virol 80:1243-1251. doi: 10.1002/jmv.21187 (Pubitemid 351706004)
16. Kuhl U, Lassner D, von Schlippenbach J, Poller W, Schultheiss HP (2012) Interferon-beta improves survival in enterovirus-associated cardiomyopathy. J Am Coll Cardiol 60:1295-1296. doi: 10.1016/j.jacc.2012.06.026
17. Kuhl U, Pauschinger M, Bock T, Klingel K, Schwimmbeck CP, Seeberg B, Krautwurm L, Poller W, Schultheiss HP, Kandolf R (2003) Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 108:945-950. doi: 10.1161/01.CIR.0000085168.02782.2C (Pubitemid 37048223)
18. Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss H-P (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with " Idiopathic" left ventricular dysfunction. Circulation 111:887-893. doi: 10.1161/01.CIR.0000155616.07901.35 (Pubitemid 40279890)
19. Kuhl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss HP (2003) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107:2793-2798. doi: 10.1161/01.CIR.0000072766.67150.51 (Pubitemid 36705988)
20. Kuhl U, Rohde M, Lassner D, Gross UM, Escher F, Schultheiss HP (2012) miRNA as activity markers in Parvo B19 associated heart disease. Herz 37:637-643. doi: 10.1007/s00059-012-3656-3
21. Moulik M, Breinholt JP, Dreyer WJ, Kearney DL, Price JF, Clunie SK, Moffett BS, Kim JJ, Rossano JW, Jefferies JL, Bowles KR, O'Brian Smith E, Bowles NE, Denfield SW, Towbin JA (2010) Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients. J Am Coll Cardiol 56:582-592. doi: 10.1016/j.jacc.2010.02.060
22. Munakata Y, Saito-Ito T, Kumura-Ishii K, Huang J, Kodera T, Ishii T, Hirabayashi Y, Koyanagi Y, Sasaki T (2005) Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood 106:3449-3456. doi: 10.1182/blood-2005-02-0536 (Pubitemid 41609180)
23. Norja P, Hokynar K, Aaltonen LM, Chen R, Ranki A, Partio EK, Kiviluoto O, Davidkin I, Leivo T, Eis-Hubinger AM, Schneider B, Fischer HP, Tolba R, Vapalahti O, Vaheri A, Soderlund-Venermo M, Hedman K (2006) Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA 103:7450-7453. doi: 10.1073/pnas.0602259103 (Pubitemid 43727853)
24. Noutsias M, Rohde M, Block A, Klippert K, Lettau O, Blunert K, Hummel M, Kuhl U, Lehmkuhl H, Hetzer R, Rauch U, Poller W, Pauschinger M, Schultheiss HP, Volk HD, Kotsch K (2008) Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies. BMC Mol Biol 9:3. doi: 10.1186/1471-2199-9- 3 (Pubitemid 351330974)
25. Noutsias M, Rohde M, Goldner K, Block A, Blunert K, Hemaidan L, Hummel M, Blohm JH, Lassner D, Kuhl U, Schultheiss HP, Volk HD, Kotsch K (2011) Expression of functional T-cell markers and T-cell receptor Vbeta repertoire in endomyocardial biopsies from patients presenting with acute myocarditis and dilated cardiomyopathy. Eur J Heart Fail 13:611-618. doi: 10.1093/eurjhf/hfr014
26. Pauschinger M, Bowles NE, Fuentes-Garcia FJ, Pham V, Kuhl U, Schwimmbeck PL, Schultheiss HP, Towbin JA (1999) Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99:1348-1354. doi: 10.1161/01.CIR.99.10.1348 (Pubitemid 29129921)
27. Piccoli C, Quarato G, Ripoli M, D'Aprile A, Scrima R, Cela O, Boffoli D, Moradpour D, Capitanio N (2009) HCV infection induces mitochondrial bioenergetic unbalance: causes and effects. Biochim Biophys Acta 1787:539-546. doi: 10.1016/j.bbabio.2008.11.00
28. Pozzuto T, von Kietzell K, Bock T, Schmidt-Lucke C, Poller W, Zobel T, Lassner D, Zeichhardt H, Weger S, Fechner H (2011) Transactivation of human parvovirus B19 gene expression in endothelial cells by adenoviral helper functions. Virology 411:50-64. doi: 10.1016/j.virol.2010.12.019
29. Schenk T, Enders M, Pollak S, Hahn R, Huzly D (2009) High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy. J Clin Microbiol 47:106-110. doi: 10.1128/JCM.01672-08
30. Schmidt-Lucke C, Spillmann F, Bock T, Kuhl U, Van Linthout S, Schultheiss HP, Tschope C (2010) Interferon beta modulates endothelial damage in patients with cardiac persistence of human parvovirus b19 infection. J Infect Dis 201:936-945. doi: 10.1086/650700
31. Servant-Delmas A, Lefrere JJ, Morinet F, Pillet S (2010) Advances in human B19 erythrovirus biology. J Virol 84:9658-9665. doi: 10.1128/JVI.00684-10
32. Vallbracht KB, Schwimmbeck PL, Kuhl U, Rauch U, Seeberg B, Schultheiss HP (2005) Differential aspects of endothelial function of the coronary microcirculation considering myocardial virus persistence, endothelial activation, and myocardial leukocyte infiltrates. Circulation 111:1784-1791. doi: 10.1161/01.CIR.0000160863.30496.9B (Pubitemid 40525143)
33. Vallbracht KB, Schwimmbeck PL, Kuhl U, Seeberg B, Schultheiss HP (2004) Endothelium-dependent flow-mediated vasodilation of systemic arteries is impaired in patients with myocardial virus persistence. Circulation 110:2938-2945. doi: 10.1161/01.CIR.0000146891.31481.CF (Pubitemid 39473621)
34. Weigel-Kelley KA, Yoder MC, Srivastava A (2003) Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 102:3927-3933. doi: 10.1182/blood-2003-05-1522 (Pubitemid 37486972)
35. Wessely R, Klingel K, Santana LF, Dalton N, Hongo M, Jonathan Lederer W, Kandolf R, Knowlton KU (1998) Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest 102:1444-1453. doi: 10.1172/JCI1972 (Pubitemid 28467573)
36. Wittchen F, Suckau L, Witt H, Skurk C, Lassner D, Fechner H, Sipo I, Ungethum U, Ruiz P, Pauschinger M, Tschope C, Rauch U, Kuhl U, Schultheiss HP, Poller W (2007) Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets. J Mol Med 85:257-271. doi: 10.1007/s00109-006-0122-9 (Pubitemid 46295241)
37. Xiong D, Yajima T, Lim BK, Stenbit A, Dublin A, Dalton ND, Summers-Torres D, Molkentin JD, Duplain H, Wessely R, Chen J, Knowlton KU (2007) Inducible cardiac-restricted expression of enteroviral protease 2A is sufficient to induce dilated cardiomyopathy. Circulation 115:94-102. doi: 10.1161/CIRCULATIONAHA. 106.631093 (Pubitemid 46058616)
38. Xu J, Nie HG, Zhang XD, Tian Y, Yu B (2011) Down-regulated energy metabolism genes associated with mitochondria oxidative phosphorylation and fatty acid metabolism in viral cardiomyopathy mouse heart. Mol Biol Rep 38:4007-4013. doi: 10.1007/s11033-010-0519-y
39. Yilmaz A, Mahrholdt H, Athanasiadis A, Vogelsberg H, Meinhardt G, Voehringer M, Kispert EM, Deluigi C, Baccouche H, Spodarev E, Klingel K, Kandolf R, Sechtem U (2008) Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis. Heart 94:1456-1463. doi: 10.1136/hrt.2007.131383
40. Zakrzewska K, Cortivo R, Tonello C, Panfilo S, Abatangelo G, Giuggioli D, Ferri C, Corcioli F, Azzi A (2005) Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures. Virus Res 114:1-5. doi: 10.1016/j.virusres.2005.05.003 (Pubitemid 41586591)